This report is being refreshed
An automated blocking check flagged a hard inconsistency in this summary (for example, figures that fail a specific reconciliation), so we've held it back while it's regenerated. That doesn't mean every published report is perfect — only that this one hit a known blocker. Check back shortly, or read the original filing on SEC EDGAR now.
About this filing
- Company
- Niki BioSolutions, Inc. (NIKI)
- Form type
- 424B3
- Filed
- June 4, 2026
- Accession
- 0001213900-26-065316